XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway

Oncogene

Volumn 28, Issue 34, 2009, Pages 3081-3092

  Tanikawa, C ^a   Furukawa, Y ^a   Yoshida, N ^a   Arakawa, H ^b   Nakamura, Y ^a   Matsuda, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Anoikis; Colorectal cancer; FAS; P53; TNFR; XEDAR

Indexed keywords

FAS ANTIGEN; PROTEIN P53; XEDAR RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; COLORECTAL TUMOR; EPIGENETICS; FOCAL ADHESION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANOIKIS; ANTIGENS, CD95; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; XEDAR RECEPTOR;

EID: 69449092723     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.154     Document Type: Article

References (39)

1. Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS, Adams DH. (1999). CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med 189: 441-446. (Pubitemid 29063265)
2. Beroud C, Soussi T. (2003). The UMD-p53 database: new mutations and analysis tools. Hum Mutat 21: 176-181. (Pubitemid 36292960)
3. Diez M, Medrano M, Muguerza JM, Ramos P, Hernandez P, Villeta R et al. (2000). Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas. Anticancer Res 20: 3907-3912. (Pubitemid 32002296)
4. Folkman J, Moscona A. (1978). Role of cell shape in growth control. Nature 273: 345-349. (Pubitemid 8344174)
5. Furutani M, Arii S, Tanaka H, Mise M, Niwano M, Harada T et al. (1997). Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma. Cancer Lett 111: 191-197. (Pubitemid 27068236)
6. Golubovskaya VM, Finch R, Kweh F, Massoll NA, Campbell-Thompson M, Wallace MR et al. (2008). p53 regulates FAK expression in human tumor cells. Mol Carcinog 47: 373-382. (Pubitemid 351614577)
7. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC et al. (1999). Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18: 3034-3043. (Pubitemid 29255612)
8. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T et al. (1994). Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555. (Pubitemid 24299821)
9. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. (1998). Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 143: 547-560. (Pubitemid 28487870)
10. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N et al. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544.
11. Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K. (2008). CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 27: 1562-1571. (Pubitemid 351347882)
12. Kitahara O, Furukawa Y, Tanaka T, Kihara C, Ono K, Yanagawa R et al. (2001). Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61: 3544-3549. (Pubitemid 32694957)
13. Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang X et al. (2003). Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res 9: 215-222. (Pubitemid 36109736)
14. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY et al. (1999). Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 59: 5683-5686.
15. Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
16. Liang F, Liang J, Wang WQ, Sun JP, Udho E, Zhang ZY. (2007). PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J Biol Chem 282: 5413-5419. (Pubitemid 47093772)
17. Liu X, Yue P, Khuri FR, Sun SY. (2005). Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Res 65: 9169-9175. (Pubitemid 41507980)
18. Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H. (2002). p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 62: 2883-2889. (Pubitemid 34525775)
19. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. (2005). The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5: 505-515. (Pubitemid 40942827)
20. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. (2002). Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 21: 2914-2918. (Pubitemid 34499391)
21. Naito A, Yoshida H, Nishioka E, Satoh M, Azuma S, Yamamoto T et al. (2002). TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci USA 99: 8766-8771. (Pubitemid 34693634)
22. Nakamura Y. (2004). Isolation of p53-target genes and their functional analysis. Cancer Sci 95: 7-11. (Pubitemid 38208400)
23. Newton K, French DM, Yan M, Frantz GD, Dixit VM. (2004). Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency. Mol Cell Biol 24: 1608-1613. (Pubitemid 38167082)
24. Nikiforov MA, Hagen K, Ossovskaya VS, Connor TM, Lowe SW, Deichman GI et al. (1996). p53 modulation of anchorage independent growth and experimental metastasis. Oncogene 13: 1709-1719. (Pubitemid 26377503)
25. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. (2000). p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862.
26. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L et al. (1995). Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55: 2752-2755.
27. Pharoah PD, Day NE, Caldas C. (1999). Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 80: 1968-1973. (Pubitemid 29391282)
28. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC et al. (1997). Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969. (Pubitemid 27087710)
29. Sinha SK, Chaudhary PM. (2004). Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism. J Biol Chem 279: 41873-41881.
30. Sinha SK, Zachariah S, Quinones HI, Shindo M, Chaudhary PM. (2002). Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor. J Biol Chem 277: 44953-44961. (Pubitemid 36159093)
31. Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A et al. (2002). The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11: 2371-2375. (Pubitemid 35174700)
32. Takakuwa T, Dong Z, Nakatsuka S, Kojya S, Harabuchi Y, Yang WI et al. (2002). Frequent mutations of Fas gene in nasal NK/T cell lymphoma. Oncogene 21: 4702-4705. (Pubitemid 34833148)
33. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K et al. (2000). A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42-49. (Pubitemid 30143125)
34. Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H. (2003). p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 5: 216-223.
35. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y et al. (1989). Allelotype of colorectal carcinomas. Science 244: 207-211.
36. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
37. Weiner TM, Liu ET, Craven RJ, Cance WG. (1993). Expression of focal adhesion kinase gene and invasive cancer. Lancet 342: 1024-1025.
38. Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID et al. (1997). KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143.
39. Yan M, Wang LC, Hymowitz SG, Schilbach S, Lee J, Goddard A et al. (2000). Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290: 523-527. (Pubitemid 30808945)